Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 127   

Articles published

GSK 1,493.59 +64.59 (4.52%)
price chart
Should you buy Tesco plc, Lloyds Banking Group plc and GlaxoSmithKline plc?
GlaxoSmithKline (LSE: GSK) is another private investor favourite. It's another high yielding share as it carries a 5.5% dividend yield covered 1.3 times by cash.
Can GlaxoSmithKline plc (ADR) Subsist Advair's Patent Expiry
GlaxoSmithKline plc (ADR) (NYSE:GSK) is in dire need of a magical respiratory molecule to patch up the increasing space in its COPD (chronic obstructive pulmonary disease) and asthma portfolio, due to the patent for blockbuster drug Advair approaching ...
Why GlaxoSmithKline plc looks set to be beaten by Inmarsat Plc
The well-reported patent-cliff headaches of recent years have made it more difficult for GlaxoSmithKline to grow as lines with high earnings lost patent exclusivity and profits plunged.
GlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100's best ...
And for 'Big Pharma' plays like GlaxoSmithKline this is a particular problem. The Brentford firm has seen earnings steadily sink during the past five years as key labels have lost patent protection.
GlaxoSmithKline plc and Royal Dutch Shell plc: 2 income champions to protect ...
GlaxoSmithKline(LSE: GSK) is one such company. The pharmaceuticals giant is a world leader in the production of consumer pharmaceutical products, such as over-the-counter medicines, toothpaste and painkillers.
Could Brexit crush 5%+ yields at GlaxoSmithKline plc and at Admiral Group plc?  Motley Fool UK
3 of my best ever dividend stocks: GlaxoSmithKline plc, Aviva plc and Royal ...
With a yield of 5.6%, GlaxoSmithKline(LSE: GSK) remains one of the highest yielding stocks in the FTSE 100. While its dividends are set to flatline over the next couple of years as it seeks to strengthen its financial position and raise its dividend ...
Should you buy into the pharma boom with GlaxoSmithKline plc and Shire plc?
There's been much talk in recent years of GlaxoSmithKline's drugs pipeline. There have been several medicine launches in recent years, yet none has turned into a blockbuster to match the success of treatments like Zantac.
GlaxoSmithKline PLC FULFIL Study Results Closed Triple EU
GlaxoSmithKline plc (LON:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced positive top-line results from the pivotal phase III FULFIL study of the investigational once-daily 'closed' triple combination therapy, fluticasone ...
Glaxo/Innoviva triple combo COPD treatment passes phase III  Proactive Investors UK
GlaxoSmithKline plc (ADR): New COPD Data Positive For Ex-Advair Franchise  Bidness ETC
Stocks Analysts Ranking Summary: Apricus Biosciences, Inc (NASDAQ:APRI ...
GlaxoSmithKline PLC has changed +1.29% up its 50 day moving average of $42.02 and moved above +4.15% from its 200 day moving average of $40.86.
Are ARM Holdings plc, GlaxoSmithKline plc and Unilever plc the FTSE 100's ...
The earnings records of ARM Holdings and medicines mammoth GlaxoSmithKline (LSE: GSK) in recent years couldn't be more different.